Documente Academic
Documente Profesional
Documente Cultură
Corresponding author.
E-mail address: robert.fairhurst@uea.ac.uk (R.E. Fairhurst).
tive alternative to biomolecules such as proteins. The rigid
and insoluble nature of monolithic MIPs, however, often
means long preparation times and can adversely affect the
properties of the materials. Amongst the techniques used to
address this problem have been suspension polymerisation
(Mayes and Mosbach, 1996), multi-step swelling (Hosoya
and Frechet, 1993) and grafting directly to a suitable sup-
port (Rckert et al., 2002; Schweitz, 2002; Nakayama et al.,
2002). In this study, three types of MIPs have been prepared
and compared for their ability to retain and enantiomerically
separate a number of drugs in the -blocker class under
HPLC and Turbulent Flow Chromatography (TFC) condi-
tions. TFC is a relatively new technique used for rapid ex-
traction and analysis of drugs from biological uids (Ayrton
et al., 1997; Chaissang et al., 2001). The solvent front
prole observed with TFC is of a plug nature rather than
parabolic (Pretorius and Smuts, 1966). The formation of
eddies promoted cross channel mass transfer and increases
0956-5663/$ see front matter 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bios.2004.01.020
R.E. Fairhurst et al. / Biosensors and Bioelectronics 20 (2004) 10981105 1099
the diffusion of small drug molecules into pores containing
reverse-phase material. Separation of plasma proteins from
bound drug is achieved by size-exclusion (60 pore size)
and slow diffusion of proteins into pores. As a result, TFC
allows the rapid passage of large biomolecules through the
column with simultaneous retention of small analytes.
2. Experimental
2.1. Chemicals
Ethylene glycol dimethacrylate (EDMA), methacrylic
acid (MAA), 2,2
C using a Jones
Chromatography Model 7990 column temperature regula-
tor and detection was performed using a Shimadzu SPD-6A
single wavelength UV detector. Wavelengths used for detec-
tion of -blockers were as follows: acebutolol 235 nm, al-
prenolol 220 nm, atenolol 226 nm, carvedilol 241 nm, meto-
prolol, nadolol and oxprenolol 223 nm, pindolol 217 nm,
propranolol 290 nm. A mobile phase composed of 70:30
acetonitrile: phosphate buffer (20 mM, pH 5.1) was used
(Haginaka and Sakai, 2000).
2.2.2. TFC
Turbulent ow conditions are achieved using high ow
rates of lowviscosity solvents in micro-bore columns packed
with particles of a large diameter. A guide to the ow char-
acteristics of a mobile phase in a packed column is given by
the Reynolds number, Re = (D
p
)/, where is the lin-
ear velocity of the mobile phase, D
p
the average diameter of
the stationary phase particles and the mobile phase kine-
matic viscosity. Turbulent ow is described by a Reynolds
number greater than 1. Large particles are therefore used to
encourage turbulent ow conditions whilst simultaneously
lowering backpressure on the column, which is particularly
important due to the high ow rates required.
This study uses TFC in dual column mode, which is per-
formed in three stages. The rst is the sample load where the
sample containing the drug of interest is loaded onto the ex-
traction column using an aqueous mobile phase. Lipophilic
drug molecules are retained on the column and polar mate-
rials are eluted to waste. Reverse ow through the extraction
column using a high organic phase then takes the drugs onto
an analytical column and through a detector of choice. Fi-
nally, the extraction column is re-equilibrated with aqueous
phase ready for the next load. Fig. 1 shows a valve diagramof
the TFC system and Table 2 gives the standard protocol used
for all TFC work throughout this study. The TFC system
consisted of HP1100 series binary and isocratic pumps and
a 2300 HTLC valve module both from Cohesive Technolo-
gies, Buckinghamshire, UK. Previously used TFC columns
from Cohesive Technologies (50 mm1 mm i.d.) were emp-
tied and packed with ground, silica-grafted or beaded mate-
rial in methanol using a home-built rig. Material was slurried
Fig. 1. The double-valve TFC system in dual column mode as used for
this study.
1100 R.E. Fairhurst et al. / Biosensors and Bioelectronics 20 (2004) 10981105
in methanol and transferred to an empty 250 mm 5 mm
i.d. column with a male end adapter. The empty TFC col-
umn was tted directly to the end of this column and the
material was pumped at 9 ml min
1
followed by 150 ml of
methanol. 5 g ml
1
propranolol in plasma was prepared by
spiking 193.84 ml of centrifuged plasma (10 min at 4
C)
with 6.16 l of 324.6 g ml
1
stock (S)-propranolol solu-
tion in acetonitrile:water (70:30). Two hundred microliters
of 1 M monochloroacetic acid solution in methanol:water
(10:90) was then added and the solution was centrifuged for
a further 30 min at 4
C by
passing heated water through the jacket. The mixture was
then subjected to UV irradiation from a distance of 5 cm
for approximately 24 h. The polymer was then ground by
hand and size-selected using steel sieves. Particles between
38 and 75 m were collected for TFC and SPE analysis.
Particles smaller than 20 m were subjected to three sedi-
mentation cycles (60 min each) in methanol to remove very
small particles and used for HPLC.
2.3.3. Beaded polymers
DPA, EDMA, MAA and (S)-propranolol were all taken
up in toluene. To this was added 20 ml PMC saturated with
toluene and polymeric surfactant. The amount of surfactant
added depended on the nal use of the beads: 25 mg for SPE
and TFC applications, 95 mg for beads designed for HPLC.
The mixture was homogenised until no surfactant precipi-
tate was visible and then added to a jacketed reaction vessel
held at 25
C then again
ltered and washed with THF, water and nally methanol
before being dried under high vacuum.
2.3.6. Polymer grafting onto silica
Initiator-modied silica (0.65 g) was added to a standard
imprinted polymer mixture with a magnetic stirrer bar in a
jacketed reaction vessel. The mixture was then subjected to
three freezethaw cycles to remove oxygen. After the nal
thaw, argon was introduced to the vessel. The vessel was
held at 25